US Stock MarketDetailed Quotes

TCON Tracon Pharmaceuticals

Watchlist
  • 0.035
  • -0.009-19.58%
15min DelayTrading Dec 2 13:05 ET
119.27KMarket Cap0.01P/E (TTM)

Tracon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
52.67%-2.77M
49.17%-2.54M
114.01%3.68M
88.78%-522K
320.48%15.05M
27.02%-5.85M
25.79%-5M
-16.25%-26.24M
9.01%-4.65M
18.96%-6.83M
Net income from continuing operations
54.84%-2.84M
62.75%-3.17M
87.68%-3.59M
106.27%439K
267.26%10.76M
-0.90%-6.29M
10.23%-8.5M
-1.63%-29.14M
9.27%-7M
7.44%-6.44M
Depreciation and amortization
-50.00%4K
-27.27%8K
-51.43%34K
-36.36%7K
-87.10%8K
-66.67%8K
140.74%11K
218.64%70K
139.29%11K
444.44%62K
Other non cash items
----
----
852.83%7.41M
--0
2,808.70%669K
276,550.00%5.53M
17,200.00%1.21M
574.39%778K
6,116.67%746K
27.78%23K
Change In working capital
95.13%-273K
-86.96%234K
-800.42%-2.15M
-268.75%-1.46M
425.57%3.12M
-138.84%-5.61M
-18.52%1.8M
-105.26%-239K
-58.86%864K
51.44%-958K
-Change in prepaid assets
-0.73%271K
-94.36%15K
289.86%269K
-86.75%51K
46.85%-321K
254.55%273K
26.07%266K
186.25%69K
2.12%385K
12.34%-604K
-Change in payables and accrued expense
-117.44%-544K
-85.68%219K
-686.04%-2.42M
-415.03%-1.51M
-1,470.62%-5.56M
228.62%3.12M
-23.24%1.53M
-106.66%-308K
-72.20%479K
72.43%-354K
Cash from discontinued investing activities
Operating cash flow
52.67%-2.77M
49.17%-2.54M
114.01%3.68M
88.78%-522K
320.48%15.05M
27.02%-5.85M
25.79%-5M
-16.25%-26.24M
9.01%-4.65M
18.96%-6.83M
Investing cash flow
Cash flow from continuing investing activities
0
0
-100.43%-17K
55.56%-4K
22.22%-7K
Net PPE purchase and sale
----
----
--0
--0
----
----
----
64.58%-17K
55.56%-4K
22.22%-7K
Net investment purchase and sale
----
----
--0
----
----
----
----
--0
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--0
--0
----
----
----
-100.43%-17K
55.56%-4K
22.22%-7K
Financing cash flow
Cash flow from continuing financing activities
9.54%1.15M
132.13%1.87M
-163.70%-12.54M
-73.23%1.32M
-186.86%-9.09M
-78.87%1.05M
-748.40%-5.82M
86.40%19.68M
800.42%4.95M
-17.94%10.47M
Net issuance payments of debt
--0
--0
-275.06%-20.5M
--0
-205.42%-10.5M
--0
-1,328.57%-10M
518.21%11.71M
590.00%3.43M
1,522.86%9.96M
Net common stock issuance
14.13%1.15M
-55.26%1.87M
0.47%7.92M
-10.01%1.32M
178.46%1.41M
-82.94%1.01M
29,757.14%4.18M
-40.36%7.88M
2,820.37%1.47M
-96.24%506K
Proceeds from stock option exercised by employees
----
----
-52.63%45K
-95.65%2K
--0
----
----
-36.24%95K
-4.17%46K
--0
Cash from discontinued financing activities
Financing cash flow
9.54%1.15M
132.13%1.87M
-163.70%-12.54M
-73.23%1.32M
-186.86%-9.09M
-78.87%1.05M
-748.40%-5.82M
86.40%19.68M
800.42%4.95M
-17.94%10.47M
Net cash flow
Beginning cash position
19.28%7.96M
-50.65%8.64M
-27.30%17.5M
-54.48%7.84M
-86.20%1.87M
-59.87%6.68M
-27.30%17.5M
-25.08%24.07M
-42.44%17.21M
-46.91%13.58M
Current changes in cash
66.25%-1.62M
93.78%-673K
-34.86%-8.86M
178.47%802K
64.12%5.96M
-56.96%-4.8M
-45.63%-10.82M
18.45%-6.57M
104.94%288K
-15.95%3.63M
End cash Position
238.47%6.34M
19.28%7.96M
-50.65%8.64M
-50.65%8.64M
-54.48%7.84M
-86.20%1.87M
-59.87%6.68M
-27.30%17.5M
-27.30%17.5M
-42.44%17.21M
Free cash flow
52.67%-2.77M
49.17%-2.54M
114.00%3.68M
88.79%-522K
320.25%15.05M
27.04%-5.85M
25.84%-5M
-16.08%-26.26M
9.10%-4.66M
18.96%-6.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 52.67%-2.77M49.17%-2.54M114.01%3.68M88.78%-522K320.48%15.05M27.02%-5.85M25.79%-5M-16.25%-26.24M9.01%-4.65M18.96%-6.83M
Net income from continuing operations 54.84%-2.84M62.75%-3.17M87.68%-3.59M106.27%439K267.26%10.76M-0.90%-6.29M10.23%-8.5M-1.63%-29.14M9.27%-7M7.44%-6.44M
Depreciation and amortization -50.00%4K-27.27%8K-51.43%34K-36.36%7K-87.10%8K-66.67%8K140.74%11K218.64%70K139.29%11K444.44%62K
Other non cash items --------852.83%7.41M--02,808.70%669K276,550.00%5.53M17,200.00%1.21M574.39%778K6,116.67%746K27.78%23K
Change In working capital 95.13%-273K-86.96%234K-800.42%-2.15M-268.75%-1.46M425.57%3.12M-138.84%-5.61M-18.52%1.8M-105.26%-239K-58.86%864K51.44%-958K
-Change in prepaid assets -0.73%271K-94.36%15K289.86%269K-86.75%51K46.85%-321K254.55%273K26.07%266K186.25%69K2.12%385K12.34%-604K
-Change in payables and accrued expense -117.44%-544K-85.68%219K-686.04%-2.42M-415.03%-1.51M-1,470.62%-5.56M228.62%3.12M-23.24%1.53M-106.66%-308K-72.20%479K72.43%-354K
Cash from discontinued investing activities
Operating cash flow 52.67%-2.77M49.17%-2.54M114.01%3.68M88.78%-522K320.48%15.05M27.02%-5.85M25.79%-5M-16.25%-26.24M9.01%-4.65M18.96%-6.83M
Investing cash flow
Cash flow from continuing investing activities 00-100.43%-17K55.56%-4K22.22%-7K
Net PPE purchase and sale ----------0--0------------64.58%-17K55.56%-4K22.22%-7K
Net investment purchase and sale ----------0------------------0--------
Cash from discontinued investing activities
Investing cash flow ----------0--0-------------100.43%-17K55.56%-4K22.22%-7K
Financing cash flow
Cash flow from continuing financing activities 9.54%1.15M132.13%1.87M-163.70%-12.54M-73.23%1.32M-186.86%-9.09M-78.87%1.05M-748.40%-5.82M86.40%19.68M800.42%4.95M-17.94%10.47M
Net issuance payments of debt --0--0-275.06%-20.5M--0-205.42%-10.5M--0-1,328.57%-10M518.21%11.71M590.00%3.43M1,522.86%9.96M
Net common stock issuance 14.13%1.15M-55.26%1.87M0.47%7.92M-10.01%1.32M178.46%1.41M-82.94%1.01M29,757.14%4.18M-40.36%7.88M2,820.37%1.47M-96.24%506K
Proceeds from stock option exercised by employees ---------52.63%45K-95.65%2K--0---------36.24%95K-4.17%46K--0
Cash from discontinued financing activities
Financing cash flow 9.54%1.15M132.13%1.87M-163.70%-12.54M-73.23%1.32M-186.86%-9.09M-78.87%1.05M-748.40%-5.82M86.40%19.68M800.42%4.95M-17.94%10.47M
Net cash flow
Beginning cash position 19.28%7.96M-50.65%8.64M-27.30%17.5M-54.48%7.84M-86.20%1.87M-59.87%6.68M-27.30%17.5M-25.08%24.07M-42.44%17.21M-46.91%13.58M
Current changes in cash 66.25%-1.62M93.78%-673K-34.86%-8.86M178.47%802K64.12%5.96M-56.96%-4.8M-45.63%-10.82M18.45%-6.57M104.94%288K-15.95%3.63M
End cash Position 238.47%6.34M19.28%7.96M-50.65%8.64M-50.65%8.64M-54.48%7.84M-86.20%1.87M-59.87%6.68M-27.30%17.5M-27.30%17.5M-42.44%17.21M
Free cash flow 52.67%-2.77M49.17%-2.54M114.00%3.68M88.79%-522K320.25%15.05M27.04%-5.85M25.84%-5M-16.08%-26.26M9.10%-4.66M18.96%-6.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-6.12%